Low-Dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis

Cureus
doi 10.7759/cureus.3943
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Low-Dose Naltrexone in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Fatigue: Biomedicine, Health and Behavior
MedicineEnvironmentalPublic HealthBehavioral NeuroscienceOccupational Health
2019English

Dose-Creep of Infliximab During Psoriasis Treatment: An Observational Study

Acta Dermato-Venereologica
DermatologyMedicine
2012English

Clearance of Psoriasis With Low Dose Cyclosporin.

BMJ
1986English

Erythrodermic Psoriasis in a Man With Monoclonal B-Cell Lymphocytosis

Cureus
2017English

Very Low Dose Naltrexone Addition in Opioid Detoxification: A Randomized, Controlled Trial

Addiction Biology
MedicinePsychiatryMental HealthPharmacology
2009English

Low Dose Naltrexone (LDN): New in the Treatment of Chronic Pain Syndromes. What Really Matters – Reduced Pain or Increased Energy?

Journal of the Neurological Sciences
Neurology
2015English

Low-Dose Baclofen for Treatment of Alcohol Dependence

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

691 in Vitro Evaluation of Naltrexone HCl 1% Topical Cream in Xematop for Psoriasis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease

Journal of Clinical Gastroenterology
Gastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy